GEJ ADENOCARCINOMA

Clinical trials for GEJ ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GEJ ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GEJ ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy targets Tough-to-Treat gut cancers

Disease control Ongoing

This study is testing whether adding a drug called tucatinib to standard cancer treatments is safe and effective for people with HER2-positive cancers of the digestive system, like stomach, colon, and gallbladder cancers. It involves about 40 participants who have advanced cancer…

Matched conditions: GEJ ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

GEJ ADENOCARCINOMA

Get alerted when new GEJ ADENOCARCINOMA trials appear

New combo therapy targets Tough-to-Treat gut cancers